Share on X (Twitter) Share on Facebook Share on Pinterest Share on LinkedIn Share on EmailKenya officially announced the introduction of a groundbreaking long-acting injectable HIV prevention drug, Lenacapavir, marking a major milestone in the country’s fight against new infections. The Ministry of Health said the new Pre-Exposure Prophylaxis (PrEP) option will provide HIV-negative individuals … Continue reading Kenya Rolls Out Long-Acting Injectable HIV Prevention Drug Lenacapavir